DCAT Week is the premier business development event for companies engaged in pharmaceutical development and manufacturing and related industries. It is organized and hosted by the Drug, Chemical & Associated Technologies Association (DCAT), a not-for-profit,...
Making drugs deliver: The formulations and technologies that will turn promising candidates into blockbuster products. Even the most promising drug candidate only becomes a successful product if it can be delivered in an effective manner. The solid dosage...
DCAT Sharp Sourcing 2017 is a conference and networking event that provides peer and customer insight on the best practices and practical ways for optimizing pharmaceutical manufacturing and supply networks. The event is designed for senior to mid-level...
The concept of a dosage form has been around for a long time. 2,400 years ago, Sumerian doctors in Nippur, an ancient city located in modern day Iraq, detailed how to make medical treatments in recipes written on clay tablets.In the millennia since, dosage...
Drug counterfeiting: a pharmaceutical industry problemCounterfeiters rely on two things: poorly secured pharmaceutical supply chains; and the fact people want to pay less for less for drugs.Most fake erectile dysfunction drugs seized in Europe contain...
Drug counterfeiting: a pharmaceutical industry problemCounterfeiters rely on two things: poorly secured pharmaceutical supply chains; and the fact people want to pay less for less for drugs.
Consumption patterns in the 4 key global markets (Europe, US, India, China)Key market drivers and restraints and their impact on consumptionCompetitive landscape in the Specialty excipients market globally and local specificitiesMarket outlook: where...
This event will examine the drug excipients market, from the historical events that have defined the sector to the debates going on at the moment to predictions about the demands that will drive it in the future.How did the DEG tragedies of the last century...
This event will examine the drug excipients market, from the historical events that have defined the sector to the debates going on at the moment to predictions about the demands that will drive it in the future.How did the DEG tragedies of the last century...
It is a well-established principal that even the most promising API, monoclonal antibody or therapeutic peptide can only be turned into an effective and marketable drug if formulated in such a way that it reaches the blood stream and is bioavailable.But,...
How healthy is demand for bioavailability enhancement services? Is the growth of the generics sector driving the market or do innovative pharma firms determine the type of solubility solutions that are available.When biopharmaceutical are injected they...
Tablets have been around for almost 200 years. In this presentation we trace the history of their development, from the accidental invention of the sustained release pill through to the latest breakthroughs in bioavailability enhancement, this talk will...
Bioavailability is a must for any new drugs and a headache for all drug development teams. In this webinar we examine the challenges scientist face and look at the technologies and services that help solve them with expert insight from Frost & Sullivan.
Identify market opportunities and share the innovations that are helping the pharmaceutical industry overcome Bioavailability Challenges. Access free webinars, white papers and network with specialists from the comfort of your desk on the 20th March on...
